NCT02173119

Can Quantitative MRI After cTACE Help Predict Survival ?

Can Quantitative MRI After Conventional Transarterial Chemoembolization (cTACE) Help Predict Survival ?

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 23 (actual)
• Sponsor: Medical College of Wisconsin · Academic / Other
• Sex: All
• Age: 18 Years – 89 Years
• Healthy volunteers: Not accepted

Summary

Transcatheter arterial chemoembolization (TACE) is a widely accepted palliative therapy for the treatment of HCC. Palliative means that it does not cure the disease prolongs your life and improves quality of life. During TACE, a mixture of chemotherapy drugs is combined with an oil called lipiodol. Lipiodol has a role as both drug carrier and embolic agent (a material that blocks blood flow to tumors). The lipiodol/chemotherapy mixture is injected into an artery (blood vessel) directly supplying blood to a HCC tumor. Lipiodol is made up of fat and water which can be seen on MRI. Therefore, MRI can be used to quantify the amount of lipiodol delivered to the HCC tumors. In this study, the investigators want to see if patient survival is related to the amount of lipiodol delivered to HCC tumors.

Conditions

• Hepatocellular Carcinoma (HCC)

Interventions

Type	Name	Description
OTHER	MRI post-TACE	Perform lipiodol delivery measurements with MRI post-TACE.

Timeline

• Start date: 2014-08-01
• Primary completion: 2018-03-07
• Completion: 2018-03-07
• First posted: 2014-06-24
• Last updated: 2019-06-10

Locations

1 site across 1 country: United States